DE, R., K, R., JC, H., MP, L., S, v. L., L, D., . . . MP, J. (2016). LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome. Molecular oncology, 10(8), 1363. https://doi.org/10.1016/j.molonc.2016.07.004
Chicago Style (17th ed.) CitationDE, Ramirez-Ardila, Ruigrok-Ritstier K, Helmijr JC, Look MP, van Laere S, Dirix L, Berns EM, and Jansen MP. "LRG1 MRNA Expression in Breast Cancer Associates with PIK3CA Genotype and with Aromatase Inhibitor Therapy Outcome." Molecular Oncology 10, no. 8 (2016): 1363. https://doi.org/10.1016/j.molonc.2016.07.004.
MLA (9th ed.) CitationDE, Ramirez-Ardila, et al. "LRG1 MRNA Expression in Breast Cancer Associates with PIK3CA Genotype and with Aromatase Inhibitor Therapy Outcome." Molecular Oncology, vol. 10, no. 8, 2016, p. 1363, https://doi.org/10.1016/j.molonc.2016.07.004.